Evidence map›Paper›PMID 31568138›Full record

ArticleThe Pediatric infectious disease journal2019

Tuberculosis Treatment Outcomes Among Children in Rural Southern Mozambique: A 12-year Retrospective Study.

Troy D Moon, Edy Nacarapa, M Elisa Verdu, Salésio Macuácua, Didier Mugabe, Wu Gong, James G Carlucci, Jose M Ramos, Emilio Valverde

Open access · greenAbstract read
In one paragraph

Article in The Pediatric infectious disease journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 14 citations in OpenAlex.

  1. Clinical Outcomes in Children With Human Immunodeficiency Virus Treated for Nonsevere Tuberculosis in the SHINE Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Troy D MoonFrom the Department of Pediatrics, Division of Pediatric Infectious Diseases.
Edy NacarapaInfectious Disease Division, Carmelo Hospital of Chókwè - Daughters of Charity, Saint Vincent of Paul, Chókwè, Gaza Province, Mozambique.
M Elisa VerduInfectious Disease Division, Carmelo Hospital of Chókwè - Daughters of Charity, Saint Vincent of Paul, Chókwè, Gaza Province, Mozambique.
Salésio MacuácuaVanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, Tennessee.
Didier MugabeVanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, Tennessee.
Wu GongDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
James G CarlucciFrom the Department of Pediatrics, Division of Pediatric Infectious Diseases.
Jose M RamosDepartment of Internal Medicine, University General Hospital of Alicante and Miguel Hernandez University of Elche, Spain.
Emilio ValverdeVanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, Tennessee.
Vanderbilt University Medical Center · USManhiça Health Research Centre · MZPediatric Infectious Diseases Society · USUniversitat de Miguel Hernández d'Elx · ES

Funding

UEM-Vanderbilt Partnership for Research in Implementation Science Mozambique (PRISM)D43TW009745 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI D. Troy Moon, Mohsin Sidat · 2015 to 2026
$3.3M
FIC NIH HHS D43 TW009745
6 · The paper itself

Abstract

backgroundGlobally, tuberculosis (TB) remains a serious cause of morbidity and mortality for children. Mozambique is 1 of 30 high TB and TB/HIV burden countries. This study aimed to assess treatment outcomes of childhood TB in Chókwè District, Mozambique.

methodsA retrospective cohort study of children <15-years-old treated for TB from 2006 to 2017 was conducted at Carmelo Hospital of Chókwè. Descriptive statistics were used to summarize patient characteristics. Treatment outcomes stratified by HIV status were compared with χ. Multivariable logistic regression was used to estimate the odds of a favorable TB treatment outcome. Kaplan-Meier curves were used to estimate the cumulative incidence of death.

resultsNine hundred thirty-three cases of childhood TB were enrolled, 45.9% of which were female and 49.6% were <5-years-old. Five hundred sixty-five (62%) children were HIV positive. Seven hundred sixty-two (83.6%) cases had a favorable TB treatment outcome. In comparison to children 0-4 years, the 5-14 age group had a higher odds of a favorable outcome [odds ratio: 2.02, 95% confidence interval: 1.42-3.05]. Being 5-14 years was associated with lower risk of death (hazard ratio: 0.435; 95% confidence interval: 0.299-0.632). Those starting anti-TB treatment ≤3 months after antiretroviral therapy initiation had a survival probability of approximately 75% at 1 year compared with 95% for those who were HIV negative.

conclusionsMost children in this cohort had favorable TB treatment outcomes. Worse outcomes were observed for younger children and if anti-TB treatment started ≤3 months after initiation of antiretroviral therapy. Rigorous screening for TB and isoniazid preventative therapy may reduce the burden of TB in this population and lead to better outcomes.

Indexed as

Rural PopulationAdolescentAntitubercular AgentsChildChild, PreschoolCross InfectionFemaleHospitalsHumansInfantInfant, NewbornMaleMozambiqueRetrospective StudiesSurvival AnalysisTreatment OutcomeAntitubercular Agents

Identifiers

PMID31568138
PMCPMC6776242
OpenAlexW2974396889

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.